Sudeep Pharma Limited (NSE:SUDEEPPHRM)
1,207.60
-0.10 (-0.01%)
Nov 12, 2026, 3:29 PM IST
Sudeep Pharma Earnings Call Transcripts
Fiscal Year 2027
-
Q2 revenue and EBITDA reached records, with PFN strength and improved margins offsetting specialty headwinds and freight costs. New capacity, specialty contracts, and battery materials offer growth opportunities, while execution, working capital, and customer commitments remain key watchpoints.